Literature DB >> 10831671

Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A.

Z A Massy, J P De Bandt, E Morelon, M Thevenin, B Lacour, H Kreis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10831671     DOI： 10.1093/ndt/15.6.928

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Post-transplant dyslipidemia: Mechanisms, diagnosis and management.

Authors:  Arnav Agarwal; G V Ramesh Prasad
Journal:  World J Transplant       Date:  2016-03-24

3.  Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.

Authors:  Wai-Johnn Sam; Christine E Chamberlain; Su-Jun Lee; Joyce A Goldstein; Douglas A Hale; Roslyn B Mannon; Allan D Kirk; Yuen Yi Hon
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

Review 4.  The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.

Authors:  Kamalesh Sankhala; Alain Mita; Kevin Kelly; Devalingam Mahalingam; Francis Giles; Monica Mita
Journal:  Target Oncol       Date:  2009-04-21       Impact factor: 4.493
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.